Month: March 2016

March 31, 2016, by NCI Staff A new study suggests that blocking calcium transfer to mitochondria (red), cells’ energy production center, may selectively kill cancer cells. Credit: Thomas Deerinck, National Center for Microscopy and Imaging Research A new study shows that blocking the transfer of calcium ions (Ca2+) into mitochondria is toxic to cancer cells
0 Comments
March 28, 2016, by NCI Staff Stained human ovarian cancer cells undergoing cell death induced by the prosaposin cyclic peptide. Credit: Randolph Watnick, Ph.D., Boston Children’s Hospital An experimental strategy for treating advanced ovarian cancer has caused tumor regression in animal models, according to a new study. The strategy uses a protein fragment, or peptide,
0 Comments
March 18, 2016, by NCI Staff Cancer statistics highlight the connection between hepatitis B and C virus infection and liver cancer. NCI constantly publishes new information on its websites, so periodically we provide updates on new content of interest to the cancer community. New Annual Report to the Nation on the Status of Cancer Released
0 Comments
March 17, 2016, by NCI Staff Images of tumor microvasculature taken by intravital microscopy. Credit: Dr. Joseph Skitzki Researchers have adapted a high-magnification technique for viewing body structures at the cellular level so that they can visualize blood vessels in human tumors in real time. Using the technique, called intravital microscopy (IVM), they found that
0 Comments
March 11, 2016, by NCI Staff NCI researchers have developed a strategy to detect T cells in patients’ peripheral blood that recognize mutations in tumors. Credit: National Cancer Institute Patients with metastatic melanoma have experienced dramatic tumor regressions in early clinical trials of adoptive cell transfer—a technique in which immune cells are collected from patients,
0 Comments
THURSDAY, March 10, 2016 (HealthDay News) — Most people appreciate the value of a good night’s sleep. But a new review has put a dollar amount on untreated insomnia in the United States, and found that it costs about $100 billion a year. The researchers said that providing drug and behavioral therapies for untreated insomnia
0 Comments
March 7, 2016, by I. Lubensky, R. Chauqui, and J. Demchok Credit: National Cancer Institute Human biospecimens, as any cancer researcher will tell you, are a foundational resource in basic and clinical cancer research. And with the launch last year of President Obama’s Precision Medicine Initiative and his announcement in January about the launch of
0 Comments
March 1, 2016, by NCI Staff Determining breast cancer risk: The discovery of BRCA1 and BRCA2 gene mutations improved screening and treatment decisions for breast and ovarian cancers. Testing for genetic mutations strongly associated with an increased breast cancer risk has risen dramatically among women younger than age 40 who are diagnosed with the disease,
0 Comments